MIRA Pharmaceuticals ( NASDAQ: MIRA ) has filed for a $100M mixed shelf offering composed of common stock, preferred stock, warrants and units, it said in a filing. The up to $19,268,571 of common stock that may be offered, issued, and sold under the sales agreement prospectus is included in the $100,000,000 of securities that may be offered, issued, and sold by MIRA Pharmaceuticals ( MIRA ) under the base prospectus. The specific terms of any securities to be offered pursuant to the base prospectus other than the shares under the sales agreement will be specified in a prospectus supplement to the base prospectus.
More on MIRA Pharmaceuticals, Inc. MIRA stock rockets 627% on preclinical results for ketamine drug (update) Seeking Alpha’s Quant Rating on MIRA Pharmaceuticals, Inc. Historical earnings data for MIRA Pharmaceuticals, Inc.
Financial information for MIRA Pharmaceuticals, Inc..